Med C Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 7.37 M
as on 31-07-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
as on 31-07-2024
- Revenue -37.72%
(FY 2023)
- Profit -49.83%
(FY 2023)
- Ebitda -32.52%
(FY 2023)
- Net Worth 189.51%
(FY 2023)
- Total Assets 61.99%
(FY 2023)
About Med C Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.37 M.
The company currently has active open charges totaling ₹0.50 M.
Amar Gali, Veera Vasireddy, and Sai Gali serve as directors at the Company.
- CIN/LLPIN
U24233TG2012PTC083743
- Company No.
083743
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2012
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Med C Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amar Gali  | Director | 20-Oct-2012 | Current |
| Veera Vasireddy | Director | 22-Jan-2015 | Current |
| Sai Gali | Director | 22-Jan-2015 | Current |
Financial Performance of Med C Pharma.
Med C Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.72% decrease. The company also saw a substantial fall in profitability, with a 49.83% decrease in profit. The company's net worth Soared by an impressive increase of 189.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Med C Pharma?
In 2023, Med C Pharma had a promoter holding of 36.06% and a public holding of 63.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Metacare Innovations LlpActive 1 year 3 monthsAmar Gali, Veera Vasireddy and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 06 Oct 2018 | ₹0.50 M | Open |
How Many Employees Work at Med C Pharma?
Unlock and access historical data on people associated with Med C Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Med C Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Med C Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
